Drug Topics

AUGUST 8, 2024

Researchers conducted a systematic review of literature exploring the misuse of opioid prescriptions for patients with chronic non-cancer pain.

201

201

STAT

AUGUST 8, 2024

Where you live has a relationship to your odds of getting cancer and surviving cancer. Epidemiologists studying this link they see in the data have focused on so-called social determinants of health — poor access to transportation, for example, could make it harder for residents to see a doctor. Places lacking grocery stores with fresh food could mean worse nutrition for locals.

Grocery Stores 145

Grocery Stores 145

Pharmacy Times

AUGUST 8, 2024

The injection adds an additional option to address emergency known or suspected opioid overdoses.

FDA 139

FDA 139

STAT

AUGUST 8, 2024

Since its emergence in 2020, Covid has jumbled the list of the 10 leading causes of deaths in the United States. It roared into third place in 2020 but has now fallen to 10th place, the National Center for Health Statistics reported Thursday.  Heart disease and cancer remained the first and second leading causes of death, followed by unintentional injuries as No. 3.

145

145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

AUGUST 8, 2024

Sam Clark, MD, PhD, founder and CEO of Terran Biosciences, discusses the implications of a potential FDA approval of MDMA-assisted therapy for PTSD.

FDA 138

FDA 138

STAT

AUGUST 8, 2024

The company that claimed its AI model could identify sexually transmitted infections from a single penis picture was shut down by the Federal Trade Commission in July. STAT wrote about the app, Calmara, and the immediate critical response it drew from patient advocates, doctors, and privacy experts in April. The founders did not adequately explain how they would protect minors from accessing the app and sensitive user information.

FDA 138

FDA 138

STAT

AUGUST 8, 2024

The liver is one of the few organs that need not be transplanted whole. It can be split into parts, with one part going to one person needing a new liver and the other part going to a second one. Removing barriers to this procedure, known as split liver transplantation, could reduce the number of deaths caused by liver failure. Here’s a real-life illustration (the names have been changed to protect privacy): Jacob was born with a rare disease that damaged his liver and needed a transplant

Hospitals 135

Hospitals 135

Pharmacy Times

AUGUST 8, 2024

Isatuximab (Sarclisa; Sanofi) in combination with standard-of-care significantly improved progression-free survival in patients with newly diagnosed multiple myeloma.

132

132

STAT

AUGUST 8, 2024

Two of the leading companies in the AI drug development field, Recursion Pharmaceuticals and Exscientia, said Thursday that they will merge into one company. The new company will continue using the Recursion name and be led by Recursion co-founder and CEO Chris Gibson. Exscientia’s interim CEO, David Hallett, will serve as the company’s science chief.

132

132

Pharmacy Times

AUGUST 8, 2024

Investigators will examine the combination with pembrolizumab and lenvatinib in patients with HER2-expressing endometrial cancer.

Vaccines 132

Vaccines 132

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

AUGUST 8, 2024

Big Health, a maker of digital treatments for mental health, has clinched Food & Drug Administration (FDA) clearance of its product for insomnia, Fierce Healthcare has learned in an a | SleepioRx, its flagship digital therapeutic, is intended for the treatment of chronic insomnia and insomnia disorder as an adjunct to usual care in adults over 18.

FDA 132

FDA 132

Pharmacy Times

AUGUST 8, 2024

The primary end point of clinical remission at week 26 was met, with 36.7% of individuals treated with RHB-104 achieving clinical remission.

132

132

Fierce Pharma

AUGUST 8, 2024

Following the commercial launch of Bavarian Nordic’s smallpox/mpox vaccine Jynneos earlier this year, the Danish company has locked up yet another supply agreement with the U.S. government. | The Biomedical Advanced Research and Development Authority (BARDA) is handing Bavarian Nordic $156.8 million to “partly replenish” Jynneos vaccine stocks in response to the 2022 outbreak of mpox, the disease formerly known as monkeypox.

Vaccines 131

Vaccines 131

Pharmacy Times

AUGUST 8, 2024

Intravenous Immunoglobulin as a therapy for patients with pyoderma gangrenosum could open new treatment avenues for the rare and challenging condition.

132

132

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

AUGUST 8, 2024

This is Part 3 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. Discovering a new drug is a big win for a pharmaceutical company, but selling it for lots of money with no competition? The cherry on top. This kind of market exclusivity is only possible because of patents.

Pharmaceutical Companies 131

Pharmaceutical Companies Pharmaceutical Companies 131

Pharmacy Times

AUGUST 8, 2024

Tirzepatide demonstrates statistically significant improvements in adult patients who have heart failure with preserved ejection fraction and obesity.

130

130

Fierce Healthcare

AUGUST 8, 2024

Mayo Clinic is partnering with startup SandboxAQ to study a new medical device that uses quantum sensing technology and advanced AI algorithms for rapid diagnosis in cardiac care, such as potential | Mayo Clinic is partnering with startup SandboxAQ to study a new medical device that uses quantum sensing technology and advanced AI algorithms for rapid diagnosis in cardiac care, such as detecting a heart attack.

Mayo Clinic 129

Mayo Clinic 129

STAT

AUGUST 8, 2024

Hunger killed an estimated 4 million people in Ukraine between 1932 and 1933 — the result of Holodomor, a famine inflicted by the Stalin-led Soviet regime. New research shows how the harm experienced during famines can extend even to people who haven’t yet been born. The study , published Thursday in Science, strengthens the link between fetal exposure to famine and increased risk for type 2 diabetes later on in life.

128

128

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

AUGUST 8, 2024

Though more than half of workers believe employer support for substance and alcohol issues is important, only 14% have access to such a benefit, a new survey finds. | The survey found that about a third of the workforce—or 60 million Americans—experience personal or family issues related to substance or alcohol use. This causes losses in productivity and increases in healthcare costs.

124

124

STAT

AUGUST 8, 2024

Eli Lilly raised its full-year revenue guidance by $3 billion, driven by massive sales of its GLP-1-based diabetes and obesity drugs Mounjaro and Zepbound. The pharma giant on Thursday boosted its forecast for 2024 sales to a range of $45.4 billion to $46.6 billion from the previously guided range of $42.4 to $43.6 billion. It also raised its guidance for adjusted earnings per share to a range of $16.10 to $16.60 from the previously guided $13.50 to $14.00.

125

125

pharmaphorum

AUGUST 8, 2024

Recursion Pharma has agreed to merge with rival AI-powered drug discovery firm Exscientia in an all-stock deal valued at $688 million

119

119

STAT

AUGUST 8, 2024

Digital Therapeutics developer Big Health this week received Food and Drug Administration clearance for SleepioRx, a prescription treatment for insomnia. Big Health already sells a wellness version of the app, called Sleepio, to employers and health plans that make the product available to their members. The app delivers a specialized type of cognitive behavioral therapy for insomnia and the company boasts that it is backed by dozens of studies.

FDA 125

FDA 125

Fierce Pharma

AUGUST 8, 2024

It was 2020 and Maryland biotech Novavax was thinking big. It had a plan to become a COVID vaccine powerhouse, with enough manufacturing capacity to supply the U.S. | As Novavax presented its quarterly earnings, finance chief Jim Kelly said the company was “actively exploring” the sale of its manufacturing facility in the Czech Republic. Novavax purchased the site in May of 2020 for $167 million with the intent of it producing more than 1 billion doses annually there.

Vaccines 119

Vaccines 119

pharmaphorum

AUGUST 8, 2024

Roche is said to be considering a sale of cancer data specialist Flatiron Health, just a few years after it bought the company for $1.

118

118

STAT

AUGUST 8, 2024

As for-profit Tenet Healthcare slims its hospital portfolio, it found an unlikely buyer for its Alabama hospitals: Florida’s Orlando Health.   Orlando Health draws more than $6 billion in annual revenue and has a profit margin that surpasses most of its peers. A hospital system executive system leader said crossing state lines to buy five Birmingham-area hospitals is part of its focus on serving the Southeastern U.S., even though most of its 17 existing hospitals are still in Fl

Hospitals 116

Hospitals 116

Fierce Healthcare

AUGUST 8, 2024

Private equity firm Prospect Medical Holdings has entered into an agreement to sell off Crozer Health to CHA Partners. | Prospect Medical Holdings has entered into an agreement to sell off Crozer Health to CHA Partners.

115

115

STAT

AUGUST 8, 2024

Once again, Novo Nordisk has been admonished by a U.K. trade group for violating voluntary marketing codes and discrediting the entire pharmaceutical industry — and the move comes just one year after the company was suspended from the organization for the way it promoted an obesity drug. In the latest episode, the company was cited for “misleading” and “unbalanced” comments made by its chief executive officer, Lars Fruergaard Jørgensen, to The Sunday Times

116

116

Fierce Healthcare

AUGUST 8, 2024

The Centers for Medicare and Medicaid Services released a final procedural notice on Wednesday to expedite Medicare coverage of novel medical devices and get the devices to Medicare benef | CMS released a final procedural notice on its TCET rule, which would expedite coverage for FDA Breakthrough medical devices. A bill is also making its way through Congress that would replace the rule.

FDA 114

FDA 114

Drug Topics

AUGUST 8, 2024

Researchers addressed the difference between prescribing guselkumab doses every 16 weeks and every 8 weeks for super responder patients with moderate to severe psoriasis.

112

112

pharmaphorum

AUGUST 8, 2024

Novartis gets FDA accelerated approval for Fabhalta in IgA nephropathy as it charts a course to blockbuster sales for the drug

FDA 111

FDA 111

Drug Topics

AUGUST 8, 2024

In a clinical trial, IPX203 was able to achieve longer good on-time with less doses compared to standard treatment.

FDA 112

FDA 112

STAT

AUGUST 8, 2024

Why did Novo Nordisk pull its paperwork to expand the use of Wegovy for a common type of heart failure? How will we know if the the government gets a good deal in the first round of drug pricing negotiations? And has Allison thought about anything other than venture capital for the last couple of months? We discuss all that and more on this week’s episode of “The Readout LOUD.

111

111

Drug Topics

AUGUST 8, 2024

With the high demand in GLP-1 medications, pharmacists are now living in an unprecedented time of filling prescriptions for high-cost brand-name drugs.

112

112